Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medical care application of L-arabinose composition

A technology of arabinose and composition, applied in the fields of biopharmaceuticals and health care

Inactive Publication Date: 2010-09-08
唐传生物科技(厦门)有限公司
View PDF2 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The above patent literature almost makes the use of L-arabinose with a specific ratio of sucrose a technical bias
On the other hand, in the prior art, there is no report about the effect of L-arabinose on the body fat index, especially the effect on the fat accumulation that has formed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical care application of L-arabinose composition
  • Medical care application of L-arabinose composition
  • Medical care application of L-arabinose composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0033] animal grouping

[0034] They were randomly divided into 3 groups. Groups A and B were the experimental drug groups, with 8 rats in each group. Group C was the control group, with 16 rats in total. Groups A, B and C were all fed high-sugar and high-fat diets, and group G was fed normal diets. There are 8 in total.

[0035] 3. How to take the drug:

[0036] Group A: The dosage of L-arabinose, the daily dosage of L-arabinose for each rabbit is 1.234g / rabbit / day, twice in the morning and in the afternoon.

[0037]Group B: According to the principle that the dosage of L-arabinose is added according to 3% of the amount of sucrose, the rabbits in group B were orally administered with a daily dose of L-arabinose: 1.11g / rabbit / day. In the morning and in the afternoon twice.

[0038] Group C: Oral administration of the same volume of distilled water. The experimental period is 2-3 months.

[0039] Group D: Feeding common feed

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of biological medicaments and health-care products, and relates to application of L-arabinose in preventing obesity and reducing weight, in particular to the application of the L-arabinose. The application of the L-arabinose composition is that the composition can effectively prevent increase of fat index in a human body caused by a high-sugar, high-fat and high-cholesterol diet, reduce the large amount of fat having been accumulated in the human body and reduce the weight through oral application.

Description

technical field [0001] The invention relates to the use of an L-arabinose composition in preventing obesity and losing weight, relates to the invention of the use of the L-arabinose composition in medicine and health care products, and belongs to the technical field of biopharmaceuticals and health care. Background technique [0002] In recent years, with the abundance of material supply and changes in lifestyle, the incidence of overweight and obesity has been increasing day by day. Obesity is not only a serious cardiovascular hazard, but also an independent high-risk factor for type 2 diabetes. 80%-90% of type 2 diabetes patients are overweight or obese. Weight gain is highly correlated with the risk of developing type 2 diabetes. At present, it is more popular to use the body mass index (BMI) to judge whether a person is overweight or obese. BMI = weight kg÷ height square m 2 (kg / m 2 ), the normal BMI value is between 18-24. If the risk of diabetes with BMI<23 is s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7004A61P3/04A23L1/30A23L2/52A23L33/125
Inventor 张厚瑞覃香香蔡爱华周玉恒陈海珊
Owner 唐传生物科技(厦门)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com